The effects of curcumin supplementation in patients with coronary heart disease
Phase 3
- Conditions
- I25.9Coronary Heart Disease.Chronic ischemic heart disease, unspecified
- Registration Number
- IRCT20170513033941N63
- Lead Sponsor
- ational Institute for Medical Research Development of Iran (NIMAD)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria: Patients aged 45-85 years
People diagnosed with type 2 diabetes and coronary heart disease.
Exclusion Criteria
Exclusion Criteria: Patients with thyroid disorders.
Severe renal insufficiency
hepatic failure
Those experiencing an acute myocardial infarction within the past 3 months
Patients undergoing cardiac surgery within the past 3 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Malondialdehyde. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method